15 Results for "

ALK-IN-5

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "ALK-IN-5" in MCE Product Catalog:

Cat. No.: HY-128569
CAS No.: 2351929-66-1
Research Areas:  

Neurological Disease

ALK-IN-5 is a potent, selective, and brain-penetrant inhibitor of anaplastic lymphoma kinase (ALK), with an IC50 of 2.9 nM .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-111482
CAS No.: 614749-78-9
Purity:  99.82%
SM 16 is a ALK5/ALK4 kinase inhibitor with Kis of 10 and 1.5 nM, respectively.
loading...
    loading...
Cat. No.: HY-12953
CAS No.: 879487-87-3
Purity:  99.92%
R-268712 is an orally active and selective ALK-5 inhibitor, with an IC50 of 2.5 nM. R-268712 inhibits the phosphorylation of Smad3 in a dose-dependent manner with an IC50 of 10.4 nM. R-268712 suppresses glomerulonephritis as well as glomerulosclerosis by inhibiting TGF-β signaling, which can be used in studies of renal fibrosis and cancer .
loading...
    loading...
Cat. No.: HY-10432G
CAS No.: 909910-43-6
A 83-01 (GMP) is A 83-01 (HY-10432) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. A 83-01 is a potent ALK4/5/7 inhibitor .
loading...
    loading...
Cat. No.: HY-173149
CAS No.: 3052084-77-9
CDD-2789 is a potent and selective ALK2 inhibitor with an IC50 0.54 μM and a Kd of 2.1 nM, respectively. CDD-2789 exhibits >120-fold selectivity over ALK3/5/6. CDD-2789 reduces activin A- and BMP2-induced SMAD1/5 phosphorylation in fibroblasts. CDD-2789 can be used for ALK2-related cancer research .
loading...
    loading...
Cat. No.: HY-164397
CAS No.: 3117862-69-5
Research Areas:  

Cancer

XMU-MP-5 is a selective inhibitor for ALK. XMU-MP-5 inhibits ALK-mutated Ba/F3 cell with IC50s of 4-50 nM, and induces apoptosis in EML4-ALK Ba/F3. XMU-MP-5 exhibits antitumor efficacy in mice .
loading...
    loading...
Cat. No.: HY-151275
CAS No.: 2785430-84-2
Research Areas:  

Cancer

ALK5-IN-28 (Compound Ex-05) is a selective ALK-5 inhibitor (IC50 ≤ 10 nM) that inhibits TGF-β-induced SMAD signaling. ALK5-IN-28 has the potential to inhibit tumor growth in vivo. ALK5-IN-28 can be used in the research of proliferative diseases such as cancer .
loading...
    loading...
Cat. No.: HY-151283
CAS No.: 2785430-89-7
Target:  

TGF-β Receptor

Research Areas:  

Cancer

ALK5-IN-33 (Compound EX-10) is a selective, orally active ALK-5 inhibitor with an IC50 ≤10 nM .
loading...
    loading...
Cat. No.: HY-112877
CAS No.: 1018953-58-6
Target:  

TGF-β Receptor

Research Areas:  

Cancer

ALK-5-IN-1 is an ALK-5 inhibitor. ALK-5-IN-1 can be used for the research of cancer, and conditions involving fibrosis .
loading...
    loading...
Cat. No.: HY-151273
CAS No.: 2785430-83-1
Target:  

TGF-β Receptor

Research Areas:  

Cancer

ALK5-IN-27 (Compound EX-04) is a potent ALK-5 inhibitor with an IC50 ≤10 nM. ALK5-IN-27 also inhibits ALK-2 (selectivity ALK2/ALK5 ≤10) .
loading...
    loading...
Cat. No.: HY-151270
CAS No.: 2785430-81-9
Target:  

TGF-β Receptor

Research Areas:  

Cancer

ALK5-IN-25 (compound EX-02) is a potent ALK-5 inhibitor with an IC50 ≤10 nM.ALK5-IN-25 also inhibits ALK-2 (selectivity ALK2/ALK5≤10). ALK5-IN-25 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-151281
CAS No.: 2785430-87-5
Target:  

TGF-β Receptor

Research Areas:  

Cancer

ALK5-IN-31 (compound Ex-08) is a selective ALK-5 inhibitor (IC50≤10 nM), inhibits TGF-β-induced SMAD signaling. ALK5-IN-31 has the potential to inhibit growth of tumour in vivo. ALK5-IN-31 can be used in study of proliferative diseases such as cancer, fibrotic diseases, and systemic sclerosis .
loading...
    loading...
Cat. No.: HY-151282
CAS No.: 2785430-88-6
Research Areas:  

Cancer

ALK5-IN-32 (compound EX-09) is a selective ALK-5 inhibitor (10 nM<IC50<100 nM), inhibits TGF-β-induced SMAD signaling. ALK5-IN-32 has the potential to inhibit growth of tumour in vivo. ALK5-IN-32 can be used in study of proliferative diseases such as cancer, fibrotic diseases, and systemic sclerosis .
loading...
    loading...
Cat. No.: HY-180956
CAS No.: 2379672-57-6
Research Areas:  

Cancer

PROTAC ALK degrader-5 (Compound 17) is an efficient ALK PROTAC degrader, with its inhibitory effects on EML4-ALK and NPM-ALK being 27.4 nM and 116.5 nM respectively. PROTAC ALK degrader-5 exhibits potent anti-proliferative activity against H3122 and Karpas 299. PROTAC ALK degrader-5 effectively inhibits the phosphorylation of ALK and STAT3. PROTAC ALK degrader-5 can be used for the study of ALK-driven malignant tumors, such as human non-small cell lung cancer and anaplastic large cell lymphoma .
loading...
    loading...
Cat. No.: HY-111482R
CAS No.: 614749-78-9
SM 16 (Standard) is the analytical standard of SM 16 (HY-111482). This product is intended for research and analytical applications. SM 16 is a ALK5/ALK4 Kinase inhibitor with Kis of 10 and 1.5 nM, respectively.
loading...
    loading...
  • 1